Se and Aprepitant drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Se (selenium) and Aprepitant (aprepitant). Common drug interactions include tachycardia among females and cholestasis among males.

The phase IV clinical study analyzes what interactions people have when they take Se and Aprepitant. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Se?

Se has active ingredients of selenium. eHealthMe is studying from 5,604 Se users. Check the latest studies of Se.

What is Aprepitant?

Aprepitant has active ingredients of aprepitant. eHealthMe is studying from 6,992 Aprepitant users. Check the latest studies of Aprepitant.



On Jul, 13, 2026

22 people who take Se and Aprepitant together, and have interactions are studied.

Se and Aprepitant drug interactions.

What are the common drug interactions of Se and Aprepitant, by gender? *:

female:

  1. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  2. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)

male:

  1. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  2. Hepatotoxicity (chemical-driven liver damage)
  3. Liver disorder (liver diseases)
  4. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
  5. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)

What are the common drug interactions of Se and Aprepitant, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  2. Hepatotoxicity (chemical-driven liver damage)
  3. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  4. Liver disorder (liver diseases)
  5. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
  6. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 16 people, 72.73%
  2. Cystic Fibrosis (disease of the secretary glands): 16 people, 72.73%
  3. High Blood Pressure: 4 people, 18.18%
  4. Type 2 Diabetes: 3 people, 13.64%
  5. Stress And Anxiety: 3 people, 13.64%
  6. Oesophageal Cancer Metastatic (cancer of oesophagues spreads to other part): 3 people, 13.64%
  7. High Blood Cholesterol: 3 people, 13.64%
  8. Diabetes: 3 people, 13.64%
  9. Gastroesophageal Cancer: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Se and Aprepitant?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Se and Aprepitant:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Se:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Aprepitant:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Se and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aprepitant and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on selenium and aprepitant (the active ingredients of Se and Aprepitant, respectively), and Se and Aprepitant (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: